The Shifting Ground in Retinal Medicine
Guidelines must adapt as retinal medicine continues to progress, and presenters on the final day of EURETINA 2022 gave a…
Lowering Treatment Burden and Maintaining Vision Gains with Aflibercept
The introduction of anti-vascular endothelial growth factor (anti-VEGF) therapy revolutionized the management and treatment of exudative retinal diseases — and…
latest posts
